Size exclusion chromatography as green support for forced degradation study of adalimumab

Size exclusion chromatography (SEC) has become a powerful tool for analysing size variants of biologic drugs in their native form. Modern SEC can be defined by the use of chromatographic columns packed with sub-3 µm particles, allowing an increase in method throughput compared to that of conventiona...

Full description

Saved in:
Bibliographic Details
Published inActa Pharmaceutica Vol. 73; no. 4; pp. 709 - 721
Main Authors Kovačić, Jelena, Klarić, Daniela Amidžić, Turk, Nikša, Mornar, Ana
Format Journal Article Paper
LanguageEnglish
Published Poland Sciendo 01.12.2023
De Gruyter Poland
Hrvatsko farmaceutsko društvo
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Size exclusion chromatography (SEC) has become a powerful tool for analysing size variants of biologic drugs in their native form. Modern SEC can be defined by the use of chromatographic columns packed with sub-3 µm particles, allowing an increase in method throughput compared to that of conventional SEC. We performed the forced degradation study of adalimumab, the first genetically engineered fully humanised immunoglobulin G1 monoclonal antibody, and evaluated tha possibilities of an advanced SEC column packed with sub-3 µm particles for elucidation of the degradation pathway. Our results revealed the main adalimumab degradation products to be antibody fragments. Acidic and basic conditions had the most intensive effect on the degradation of the adalimumab while the drug exhibits relative stability under thermal and photolytic stress conditions. The AGREE and AGREEprep calculators were used for the evaluation of the environmental performance of the forced degradation procedure. The results of the green score evaluation are presented as round pictograms with a circle in the centre that shows the overall score of 0.81 and 0.61, respectively. Both pictograms are highlighted in green, indicating the eco-friendly conditions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
310115
ISSN:1846-9558
1330-0075
1846-9558
DOI:10.2478/acph-2023-0044